康涅狄格州和新泽西州第三磨牙拔除后的阿片类药物处方模式。

Q3 Medicine Anesthesia progress Pub Date : 2022-12-01 DOI:10.2344/anpr-69-02-12
Steven Halepas, Cameron Christiansen, Alia Koch, Shahid R Aziz, David M Shafer, Elie M Ferneini
{"title":"康涅狄格州和新泽西州第三磨牙拔除后的阿片类药物处方模式。","authors":"Steven Halepas,&nbsp;Cameron Christiansen,&nbsp;Alia Koch,&nbsp;Shahid R Aziz,&nbsp;David M Shafer,&nbsp;Elie M Ferneini","doi":"10.2344/anpr-69-02-12","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>In recent years, opioid misuse has resulted in much scrutiny on providers' prescribing habits. The purpose of this study was to analyze prescribing habits in the context of third molar extractions as a model for promoting better postsurgical pain management.</p><p><strong>Methods: </strong>This was a cross-sectional survey of oral maxillofacial surgeons in Connecticut and New Jersey. A total of 291 practitioners were contacted to complete an online survey using Qualtrics Research Services to determine prescribing habits following third molar extractions.</p><p><strong>Results: </strong>The most common approach for postoperative analgesia was nonsteroidal anti-inflammatory drugs (NSAIDs) and an opioid/acetaminophen (APAP) combination as 2 separate prescriptions, reported by 36% of participants. The combination of hydrocodone/APAP was the most common opioid formulation, and an average of 10.93 ± 4.51 opioid pills were prescribed with a maximum of 20 pills reported. Most providers (79%) consistently provided patients with opioid information. Only 22% reported always checking opioid-monitoring programs; however, providers were more likely to check if prescribing more than ∼11 opioid pills (P = .0228). Most reported using dexamethasone (82%) and bupivacaine (56%) intraoperatively, while ketorolac was less common (15%). No association was found between the quantity of opioids prescribed and the use of intraoperative ketorolac, steroids, or bupivacaine (P > .05).</p><p><strong>Conclusion: </strong>There remains to be a universal standard for using opioids for postoperative pain management in dentistry. Providers should be mindful when prescribing opioids and consider using NSAIDs and APAP for baseline pain plus a separate opioid prescription for breakthrough pain. Additional focus on minimizing the quantity of opioids prescribed and self-reflecting on prescribing and practice habits to further reduce opioid-related complications is warranted.</p>","PeriodicalId":7818,"journal":{"name":"Anesthesia progress","volume":"69 4","pages":"9-14"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773415/pdf/i1878-7177-69-4-9.pdf","citationCount":"0","resultStr":"{\"title\":\"Opioid-Prescribing Patterns in Connecticut and New Jersey Following Third Molar Extractions.\",\"authors\":\"Steven Halepas,&nbsp;Cameron Christiansen,&nbsp;Alia Koch,&nbsp;Shahid R Aziz,&nbsp;David M Shafer,&nbsp;Elie M Ferneini\",\"doi\":\"10.2344/anpr-69-02-12\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>In recent years, opioid misuse has resulted in much scrutiny on providers' prescribing habits. The purpose of this study was to analyze prescribing habits in the context of third molar extractions as a model for promoting better postsurgical pain management.</p><p><strong>Methods: </strong>This was a cross-sectional survey of oral maxillofacial surgeons in Connecticut and New Jersey. A total of 291 practitioners were contacted to complete an online survey using Qualtrics Research Services to determine prescribing habits following third molar extractions.</p><p><strong>Results: </strong>The most common approach for postoperative analgesia was nonsteroidal anti-inflammatory drugs (NSAIDs) and an opioid/acetaminophen (APAP) combination as 2 separate prescriptions, reported by 36% of participants. The combination of hydrocodone/APAP was the most common opioid formulation, and an average of 10.93 ± 4.51 opioid pills were prescribed with a maximum of 20 pills reported. Most providers (79%) consistently provided patients with opioid information. Only 22% reported always checking opioid-monitoring programs; however, providers were more likely to check if prescribing more than ∼11 opioid pills (P = .0228). Most reported using dexamethasone (82%) and bupivacaine (56%) intraoperatively, while ketorolac was less common (15%). No association was found between the quantity of opioids prescribed and the use of intraoperative ketorolac, steroids, or bupivacaine (P > .05).</p><p><strong>Conclusion: </strong>There remains to be a universal standard for using opioids for postoperative pain management in dentistry. Providers should be mindful when prescribing opioids and consider using NSAIDs and APAP for baseline pain plus a separate opioid prescription for breakthrough pain. Additional focus on minimizing the quantity of opioids prescribed and self-reflecting on prescribing and practice habits to further reduce opioid-related complications is warranted.</p>\",\"PeriodicalId\":7818,\"journal\":{\"name\":\"Anesthesia progress\",\"volume\":\"69 4\",\"pages\":\"9-14\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773415/pdf/i1878-7177-69-4-9.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anesthesia progress\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2344/anpr-69-02-12\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesia progress","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2344/anpr-69-02-12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:近年来,阿片类药物滥用导致了许多审查提供者的处方习惯。本研究的目的是分析第三磨牙拔除的处方习惯,作为促进更好的术后疼痛管理的模型。方法:对康涅狄格州和新泽西州的口腔颌面外科医生进行横断面调查。总共联系了291名医生,使用质量研究服务完成了一项在线调查,以确定第三磨牙拔牙后的处方习惯。结果:最常见的术后镇痛方法是非甾体抗炎药(NSAIDs)和阿片类药物/对乙酰氨基酚(APAP)联合作为2个单独的处方,有36%的参与者报告。最常见的阿片类药物处方为氢可酮/APAP联用,平均处方量为10.93±4.51片,最多20片。大多数提供者(79%)始终如一地向患者提供阿片类药物信息。只有22%的人表示经常检查阿片类药物监测程序;然而,提供者更有可能检查处方是否超过11片阿片类药物(P = 0.0228)。大多数报告术中使用地塞米松(82%)和布比卡因(56%),而酮妥拉克较少见(15%)。处方阿片类药物的数量与术中酮罗拉酸、类固醇或布比卡因的使用没有关联(P > 0.05)。结论:阿片类药物用于牙科术后疼痛管理仍有一个普遍的标准。提供者在开阿片类药物处方时应注意,并考虑使用非甾体抗炎药和APAP治疗基线疼痛,外加单独的阿片类药物处方治疗突破性疼痛。有必要进一步关注尽量减少阿片类药物的处方数量,并对处方和实践习惯进行自我反思,以进一步减少阿片类药物相关并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Opioid-Prescribing Patterns in Connecticut and New Jersey Following Third Molar Extractions.

Objective: In recent years, opioid misuse has resulted in much scrutiny on providers' prescribing habits. The purpose of this study was to analyze prescribing habits in the context of third molar extractions as a model for promoting better postsurgical pain management.

Methods: This was a cross-sectional survey of oral maxillofacial surgeons in Connecticut and New Jersey. A total of 291 practitioners were contacted to complete an online survey using Qualtrics Research Services to determine prescribing habits following third molar extractions.

Results: The most common approach for postoperative analgesia was nonsteroidal anti-inflammatory drugs (NSAIDs) and an opioid/acetaminophen (APAP) combination as 2 separate prescriptions, reported by 36% of participants. The combination of hydrocodone/APAP was the most common opioid formulation, and an average of 10.93 ± 4.51 opioid pills were prescribed with a maximum of 20 pills reported. Most providers (79%) consistently provided patients with opioid information. Only 22% reported always checking opioid-monitoring programs; however, providers were more likely to check if prescribing more than ∼11 opioid pills (P = .0228). Most reported using dexamethasone (82%) and bupivacaine (56%) intraoperatively, while ketorolac was less common (15%). No association was found between the quantity of opioids prescribed and the use of intraoperative ketorolac, steroids, or bupivacaine (P > .05).

Conclusion: There remains to be a universal standard for using opioids for postoperative pain management in dentistry. Providers should be mindful when prescribing opioids and consider using NSAIDs and APAP for baseline pain plus a separate opioid prescription for breakthrough pain. Additional focus on minimizing the quantity of opioids prescribed and self-reflecting on prescribing and practice habits to further reduce opioid-related complications is warranted.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Anesthesia progress
Anesthesia progress Medicine-Medicine (all)
CiteScore
0.90
自引率
0.00%
发文量
32
期刊介绍: Anesthesia Progress is a peer-reviewed journal and the official publication of the American Dental Society of Anesthesiology. The journal is dedicated to providing a better understanding of the advances being made in the art and science of pain and anxiety control in dentistry.
期刊最新文献
Evaluation of Sedation Levels Using SedLine During Intravenous Sedation for Dental Procedures: A Case-Series Study. Cardiac Arrest Due to Pacing Failure From Pilsicainide Poisoning. A New Dental Specialty in Canada. Literature Review for Office-Based Anesthesia. Hypotension Without Skin Symptoms at Local Anesthesia in Dental Treatment: Anaphylaxis? Or Vasovagal Reaction?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1